Postoperative inotrope and vasopressor use following CABG: Outcome data from the CAPS-Care study

Journal of Cardiac Surgery

Volumn 26, Issue 6, 2011, Pages 572-578

  Williams, Judson B ^a,b   Hernandez, Adrian F ^a   Li, Shuang ^a   Dokholyan, Rachel S ^a   O'Brien, Sean M ^a   Smith, Peter K ^b   Ferguson, T Bruce ^c   Peterson, Eric D ^a  

^a DUKE CLINICAL RESEARCH INSTITUTE   (United States)

^b DUKE UNIVERSITY MEDICAL CENTER   (United States)

^c EAST CAROLINA UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENALIN; DOBUTAMINE; DOPAMINE; HYPERTENSIVE FACTOR; INOTROPIC AGENT; MILRINONE; NORADRENALIN; PHENYLEPHRINE; VASOPRESSIN;

AGED; ARTICLE; BLOOD TRANSFUSION; CORONARY ARTERY BYPASS GRAFT; FEMALE; HEART ATRIUM FIBRILLATION; HUMAN; KIDNEY FAILURE; LIMB ISCHEMIA; MAJOR CLINICAL STUDY; MALE; MITRAL VALVE REGURGITATION; OUTCOME ASSESSMENT; POSTOPERATIVE PERIOD; SURGICAL MORTALITY;

AGED; CARDIOTONIC AGENTS; CORONARY ARTERY BYPASS; FEMALE; FOLLOW-UP STUDIES; HOSPITAL MORTALITY; HUMANS; INCIDENCE; MALE; MYOCARDIAL ISCHEMIA; PERIOPERATIVE CARE; POSTOPERATIVE COMPLICATIONS; RETROSPECTIVE STUDIES; TREATMENT OUTCOME; UNITED STATES; VASOCONSTRICTOR AGENTS;

EID: 82455212056     PISSN: 08860440     EISSN: 15408191     Source Type: Journal    
DOI: 10.1111/j.1540-8191.2011.01301.x     Document Type: Article

References (17)

1. Williams JB, Delong ER, Peterson ED, et al: Secondary prevention after coronary artery bypass graft surgery: Findings of a national randomized controlled trial and sustained society-led incorporation into practice. Circulation 2011; 123: 39-45.
2. Holman WL, Sansom M, Kiefe CI, et al: Alabama coronary artery bypass grafting project: Results from phase II of a statewide quality improvement initiative. Ann Surg 2004; 239: 99-109. (Pubitemid 38176379)
3. Ahmed I, House CM, Nelson WB,: Predictors of inotrope use in patients undergoing concomitant coronary artery bypass graft (CABG) and aortic valve replacement (AVR) surgeries at separation from cardiopulmonary bypass (CPB). J Cardiothorac Surg 2009; 4: 24.
4. Butterworth JF, Legault C, Royster RL, et al: Factors that predict the use of positive inotropic drug support after cardiac valve surgery. Anesth Analg 1998; 86: 461-467. (Pubitemid 28119400)
5. Royster RL, Butterworth JF, Prough DS, et al: Preoperative and intraoperative predictors of inotropic support and long-term outcome in patients having coronary artery bypass grafting. Anesth Analg 1991; 72: 729-736.
6. Maganti MD, Borger MA, Ivanov J, et al: Predictors of low cardiac output syndrome after isolated aortic valve surgery. Circulation 2005; 112 (9 Suppl): I448-I452. (Pubitemid 41266713)
7. Gillies M, Bellomo R, Doolan L, et al: Bench-to-bedside review: Inotropic drug therapy after adult cardiac surgery-A systematic literature review. Crit Care 2005; 9: 266-279. (Pubitemid 40796804)
8. Lobato EB, Urdaneta F, Martin TD, et al: Effects of milrinone versus epinephrine on grafted internal mammary artery flow after cardiopulmonary bypass. J Cardiothorac Vasc Anesth 2000; 14: 9-11. (Pubitemid 30114927)
9. Hernandez AF, Li S, Dokholyan RS, et al: Variation in perioperative vasoactive therapy in cardiovascular surgical care: Data from the Society of Thoracic Surgeons. Am Heart J 2009; 158: 47-52.
10. Bastien O, Vallet B,: French multicentre survey on the use of inotropes after cardiac surgery. Critical Care 2005; 9: 241-242. (Pubitemid 40796794)
11. Welke KF, Ferguson TB, Coombs LP, et al: Validity of the Society of Thoracic Surgeons National Adult Cardiac Surgery Database. Ann Thorac Surg 2004; 77: 1137-1139. (Pubitemid 38452331)
12. Welke KF, Peterson ED, Vaughan-Sarrazin MS, et al: Comparison of cardiac surgery volumes and mortality rates between the Society of Thoracic Surgeons and Medicare databases from 1993 through 2001. Ann Thorac Surg 2007; 84: 1538-1546. (Pubitemid 47588140)
13. Kastrup M, Markewitz A, Spies C, et al: Current practice of hemodynamic monitoring and vasopressor and inotropic therapy in post-operative cardiac surgery patients in Germany: Results from a postal survey. Acta Anaesthesiol Scand 2007; 51: 347-358.
14. Kikura M, Sato S,: The efficacy of preemptive milrinone or amrinone therapy in patients undergoing coronary artery bypass grafting. Anesth Analg 2002; 94: 22-30. (Pubitemid 34038713)
15. Hoffman TM, Wernovsky G, Atz AM, et al: Efficacy and safety of milrinone in preventing low cardiac output syndrome in infants and children after corrective surgery for congenital heart disease. Circulation 2003; 107: 996-1002. (Pubitemid 36258723)
16. Cuffe MS, Califf RM, Adams KF Jr, et al: Outcomes of a Prospective Trial of Intravenous Milrinone for Exacerbations of Chronic Heart Failure (OPTIME-CHF) investigators. Short-term intravenous milrinone for acute exacerbation of chronic heart failure: A randomized controlled trial. JAMA 2002; 287: 1541-1547.
17. Sostaric M, Gersak B, Novak-Jankovic V,: Early extubation and fast-track anesthetic technique for endoscopic cardiac surgery. Heart Surg Forum 2010; 13: 190-194.